Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Escherichia coli strain Nissle 1917-from bench to bedside and back: history of a special Escherichia coli strain with probiotic properties.

Sonnenborn U.

FEMS Microbiol Lett. 2016 Oct;363(19). pii: fnw212. Epub 2016 Sep 11. Review.

PMID:
27619890
2.
3.

Complete genome sequence of the gram-negative probiotic Escherichia coli strain Nissle 1917.

Reister M, Hoffmeier K, Krezdorn N, Rotter B, Liang C, Rund S, Dandekar T, Sonnenborn U, Oelschlaeger TA.

J Biotechnol. 2014 Oct 10;187:106-7. doi: 10.1016/j.jbiotec.2014.07.442. Epub 2014 Aug 2.

PMID:
25093936
4.

A modified MacConkey agar for selective enumeration of necrotoxigenic E. coli O55 and probiotic E. coli Nissle 1917.

Splichalova A, Splichal I, Sonnenborn U, Rada V.

J Microbiol Methods. 2014 Sep;104:82-6. doi: 10.1016/j.mimet.2014.06.017. Epub 2014 Jul 4.

PMID:
25008462
5.

Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7.

Rund SA, Rohde H, Sonnenborn U, Oelschlaeger TA.

Int J Med Microbiol. 2013 Jan;303(1):1-8. doi: 10.1016/j.ijmm.2012.11.006. Epub 2013 Jan 10.

PMID:
23312798
6.

Differential targeting of the E-Cadherin/β-Catenin complex by gram-positive probiotic lactobacilli improves epithelial barrier function.

Hummel S, Veltman K, Cichon C, Sonnenborn U, Schmidt MA.

Appl Environ Microbiol. 2012 Feb;78(4):1140-7. doi: 10.1128/AEM.06983-11. Epub 2011 Dec 16.

7.

Identification of specific miRNAs targeting proteins of the apical junctional complex that simulate the probiotic effect of E. coli Nissle 1917 on T84 epithelial cells.

Veltman K, Hummel S, Cichon C, Sonnenborn U, Schmidt MA.

Int J Biochem Cell Biol. 2012 Feb;44(2):341-9. doi: 10.1016/j.biocel.2011.11.006. Epub 2011 Nov 15.

PMID:
22101077
8.

Anti-inflammatory modulation of immune response by probiotic Escherichia coli Nissle 1917 in human blood mononuclear cells.

Güttsches AK, Löseke S, Zähringer U, Sonnenborn U, Enders C, Gatermann S, Bufe A.

Innate Immun. 2012 Apr;18(2):204-16. doi: 10.1177/1753425910396251. Epub 2011 Mar 7.

PMID:
21382908
9.

Interference of Bifidobacterium choerinum or Escherichia coli Nissle 1917 with Salmonella Typhimurium in gnotobiotic piglets correlates with cytokine patterns in blood and intestine.

Splichalova A, Trebichavsky I, Rada V, Vlkova E, Sonnenborn U, Splichal I.

Clin Exp Immunol. 2011 Feb;163(2):242-9. doi: 10.1111/j.1365-2249.2010.04283.x. Epub 2010 Dec 13.

10.

Yeasts in the gut: from commensals to infectious agents.

Schulze J, Sonnenborn U.

Dtsch Arztebl Int. 2009 Dec;106(51-52):837-42. doi: 10.3238/arztebl.2009.0837. Epub 2009 Dec 18. Review.

11.

Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88.

Remer KA, Bartrow M, Roeger B, Moll H, Sonnenborn U, Oelschlaeger TA.

Int J Med Microbiol. 2009 Nov;299(7):467-78. doi: 10.1016/j.ijmm.2009.03.003. Epub 2009 May 20.

PMID:
19467927
12.

Cell-free supernatants of Escherichia coli Nissle 1917 modulate human colonic motility: evidence from an in vitro organ bath study.

Bär F, Von Koschitzky H, Roblick U, Bruch HP, Schulze L, Sonnenborn U, Böttner M, Wedel T.

Neurogastroenterol Motil. 2009 May;21(5):559-66, e16-7. doi: 10.1111/j.1365-2982.2008.01258.x. Epub 2009 Feb 11.

PMID:
19220758
13.

The probiotic Escherichia coli strain Nissle 1917 induces gammadelta T cell apoptosis via caspase- and FasL-dependent pathways.

Guzy C, Paclik D, Schirbel A, Sonnenborn U, Wiedenmann B, Sturm A.

Int Immunol. 2008 Jul;20(7):829-40. doi: 10.1093/intimm/dxn041. Epub 2008 Apr 30.

PMID:
18448456
14.

Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair.

Zyrek AA, Cichon C, Helms S, Enders C, Sonnenborn U, Schmidt MA.

Cell Microbiol. 2007 Mar;9(3):804-16. Epub 2006 Nov 3.

PMID:
17087734
15.

Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways.

Grabig A, Paclik D, Guzy C, Dankof A, Baumgart DC, Erckenbrecht J, Raupach B, Sonnenborn U, Eckert J, Schumann RR, Wiedenmann B, Dignass AU, Sturm A.

Infect Immun. 2006 Jul;74(7):4075-82.

16.

Effect of E. coli Nissle 1917 on post-inflammatory visceral sensory function in a rat model.

Liebregts T, Adam B, Bertel A, Jones S, Schulze J, Enders C, Sonnenborn U, Lackner K, Holtmann G.

Neurogastroenterol Motil. 2005 Jun;17(3):410-4.

PMID:
15916628
17.

Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling.

Sturm A, Rilling K, Baumgart DC, Gargas K, Abou-Ghazalé T, Raupach B, Eckert J, Schumann RR, Enders C, Sonnenborn U, Wiedenmann B, Dignass AU.

Infect Immun. 2005 Mar;73(3):1452-65.

18.

NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium.

Wehkamp J, Harder J, Wehkamp K, Wehkamp-von Meissner B, Schlee M, Enders C, Sonnenborn U, Nuding S, Bengmark S, Fellermann K, Schröder JM, Stange EF.

Infect Immun. 2004 Oct;72(10):5750-8.

19.

Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917.

Grozdanov L, Raasch C, Schulze J, Sonnenborn U, Gottschalk G, Hacker J, Dobrindt U.

J Bacteriol. 2004 Aug;186(16):5432-41.

20.

The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens.

Altenhoefer A, Oswald S, Sonnenborn U, Enders C, Schulze J, Hacker J, Oelschlaeger TA.

FEMS Immunol Med Microbiol. 2004 Apr 9;40(3):223-9.

Supplemental Content

Loading ...
Support Center